Insider · CIK 0001829069

Sanna Bastiano

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001829069

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28.8K sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28.8K sh	—	—	28,828
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.5K sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,172 sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,172 sh	—	—	1,172
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.5K sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.4K sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.4K sh	—	—	26,400
2023-06-01	ACETAdicet Bio, Inc.A Award	Director	AAward	+5,900 sh	—	—	5,900
2023-06-01	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.4K sh	—	—	26,400
2023-05-08	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−2,850 sh	$350.00	−$998K	32,038
2023-05-05	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−422 sh	$350.03	−$148K	34,888
2023-05-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−2,053 sh	$350.44	−$719K	36,038
2023-05-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−728 sh	$351.60	−$256K	35,310
2023-05-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−1,411 sh	$350.32	−$494K	38,302
2023-05-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−42 sh	$351.65	−$14.8K	38,260
2023-05-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−169 sh	$353.24	−$59.7K	38,091
2023-04-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−874 sh	$325.70	−$285K	46,406
2023-04-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−4,068 sh	$326.45	−$1.33M	42,338
2023-04-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−2,625 sh	$327.43	−$860K	39,713
2023-04-04	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−211 sh	$314.22	−$66.3K	47,591
2023-04-04	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−94 sh	$315.66	−$29.7K	47,497
2023-04-04	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−90 sh	$316.76	−$28.5K	47,407
2023-04-04	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−96 sh	$317.65	−$30.5K	47,311
2023-04-04	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−31 sh	$318.68	−$9,879.08	47,280
2023-03-31	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Cell & Genetic Therapies	FTax Payment	−1,466 sh	$313.74	−$460K	47,802
2023-03-16	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−2,482 sh	$300.54	−$746K	49,532
2023-03-16	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−264 sh	$301.07	−$79.5K	49,268
2023-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Cell & Genetic Therapies	FTax Payment	−3,970 sh	$289.12	−$1.15M	52,014
2023-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Cell & Genetic Therapies	FTax Payment	−3,750 sh	$292.85	−$1.1M	55,984
2023-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−1,902 sh	$300.29	−$571K	60,013
2023-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−279 sh	$301.11	−$84K	59,734
2023-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Cell & Genetic Therapies	FTax Payment	−4,340 sh	$298.26	−$1.29M	62,028
2023-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−113 sh	$300.39	−$33.9K	61,915
2023-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Cell & Genetic Therapies	FTax Payment	−902 sh	$294.33	−$265K	66,368
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Cell & Genetic Therapies	AAward	+9,092 sh	—	—	47,090
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Cell & Genetic Therapies	AAward	+12.3K sh	—	—	59,404
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Cell & Genetic Therapies	AAward	+7,866 sh	—	—	67,270
2023-01-31	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−106 sh	$325.00	−$34.5K	37,998
2022-11-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−56 sh	$310.10	−$17.4K	38,368
2022-11-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−39 sh	$311.17	−$12.1K	38,329
2022-11-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−100 sh	$312.40	−$31.2K	38,229
2022-11-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−81 sh	$313.37	−$25.4K	38,148
2022-11-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−12 sh	$314.43	−$3,773.16	38,136
2022-11-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−10 sh	$315.68	−$3,156.8	38,126
2022-11-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−22 sh	$317.77	−$6,990.94	38,104
2022-11-01	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Cell & Genetic Therapies	FTax Payment	−768 sh	$312.84	−$240K	38,424
2022-10-18	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Cell & Genetic Therapies	SSale	−1,503 sh	$300.02	−$451K	39,480

Recent filings

Accepted (ET)
Aug 164
Sanna Bastiano0001209191-23-046097
SEC(opens sec.gov)
Jun 24
Sanna Bastiano0001209191-23-033960
SEC(opens sec.gov)
May 94
Sanna Bastiano0001209191-23-028243
SEC(opens sec.gov)
May 44
Sanna Bastiano0001209191-23-027374
SEC(opens sec.gov)
Apr 144
Sanna Bastiano0001209191-23-024312
SEC(opens sec.gov)

Companies

Address

C/O ADICET BIO, INC. 500 BOYLSTON STREET, 13TH FLOOR

BOSTON, MA, 02116